Negligent Drug Design Claims May Increase In Pa.

Law360, New York (February 4, 2014, 4:02 PM EST) -- Recently, The Pennsylvania Supreme Court ruled under its state law that pharmaceutical companies such as Pfizer Inc. are prone to being sued for a “lack of due care.” The Supreme Court ruling derived from the initial 2006 Wyeth lawsuit filed (Patsy Lance, et al. v. Wyeth, et al., Nos. 17 EAP 2011 and 18 EAP 2011, Pa. Sup.; 2014 Pa. LEXIS 205), at Philadelphia Common Pleas Court. Wyeth Pharmaceuticals Inc. was acquired by Pfizer (NYSE: PFE) for $68 billion in 2009. The proposed ruling aims to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.